EMQs in Clinical Medicine.pdf - Peshawar Medical College
EMQs in Clinical Medicine.pdf - Peshawar Medical College
EMQs in Clinical Medicine.pdf - Peshawar Medical College
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Adverse drug reactions – answers 237<br />
92 Adverse drug reactions<br />
Answers: E B J M G<br />
E<br />
B<br />
J<br />
M<br />
G<br />
A 35-year-old woman presents with polyuria and polydipsia. She<br />
says that she is on medication for bipolar disorder.<br />
Polyuria and polydipsia are suggestive of diabetes <strong>in</strong>sipidus. Lithium is<br />
a well-recognized drug cause of nephrogenic diabetes <strong>in</strong>sipidus.<br />
Lithium has a narrow therapeutic w<strong>in</strong>dow and so therapeutic drug<br />
monitor<strong>in</strong>g is very important. Signs of toxicity <strong>in</strong>clude tremor, ataxia<br />
and dysarthria.<br />
A 25-year-old man on anti-TB therapy compla<strong>in</strong>s of orange<br />
discoloration of the ur<strong>in</strong>e.<br />
Rifampic<strong>in</strong> can cause bodily secretions, such as saliva, tears and ur<strong>in</strong>e, to<br />
be coloured orange–red. Rifampic<strong>in</strong> is a potent cytochrome P450 <strong>in</strong>ducer<br />
and thus has the potential to reduce plasma levels of cytochrome P450<br />
substrates. If a drug is prescribed with rifampic<strong>in</strong>, the dose needs to be<br />
<strong>in</strong>creased to compensate.<br />
A 56-year-old man compla<strong>in</strong>s of a persistent dry cough a few weeks<br />
after start<strong>in</strong>g new anti-hypertensive medication.<br />
Angiotens<strong>in</strong>-convert<strong>in</strong>g enzyme (ACE) (also known as k<strong>in</strong><strong>in</strong>ase II)<br />
converts <strong>in</strong>active angiotens<strong>in</strong> I to the vasoconstrictor angiotens<strong>in</strong> II. In<br />
this way, ACE <strong>in</strong>hibitors reduce angiotens<strong>in</strong> II levels.<br />
ACE also <strong>in</strong>activates bradyk<strong>in</strong><strong>in</strong> and so ACE <strong>in</strong>hibitors may cause a<br />
persistent dry cough result<strong>in</strong>g from <strong>in</strong>creased levels of bradyk<strong>in</strong><strong>in</strong>.<br />
A 50-year-old woman compla<strong>in</strong>s of a metallic taste <strong>in</strong> the mouth and<br />
anorexia after start<strong>in</strong>g medication for her diabetes.<br />
Metform<strong>in</strong> is particularly useful <strong>in</strong> treat<strong>in</strong>g overweight patients with type<br />
2 diabetes mellitus because of its anorectic effect (sulphonylureas can<br />
encourage weight ga<strong>in</strong>). Metform<strong>in</strong> reduces glucose absorption from the<br />
gut, <strong>in</strong>hibits liver gluconeogenesis and <strong>in</strong>creases uptake of glucose <strong>in</strong>to<br />
tissues. Hypoglycaemia does not usually occur with metform<strong>in</strong> treatment.<br />
Lactic acidosis is a very rare complication of metform<strong>in</strong> treatment but<br />
carries a high mortality. Metform<strong>in</strong> is therefore contra<strong>in</strong>dicated <strong>in</strong><br />
patients who are at risk of lactic acidosis, e.g. significant renal impairment.<br />
Metform<strong>in</strong> should be replaced with <strong>in</strong>sul<strong>in</strong> before elective surgery.<br />
A 55-year-old woman presents with weight ga<strong>in</strong>, hypertension and<br />
proximal myopathy.<br />
The use of corticosteroids can give rise to an iatrogenic Cush<strong>in</strong>g’s<br />
syndrome. Therefore, long-term adverse effects of steroid treatment<br />
<strong>in</strong>clude diabetes, osteoporosis and hypertension.